Cardiovascular effects of SL65.0472, a 5-HT receptor antagonist

By O'Connor S.E.   Grosset A.   Drieu La Rochelle C.   Gautier E.   Bidouard J.-P.   Robineau P.   Caille D.   Janiak P.  

European Journal of Pharmacology, Vol. 414, Iss. 2, 2001-03 ,pp. : 259-269

Elsevier

Access to resources Recommend Favorite

The corticosterone-enhancing effects of the 5-HT 1A receptor antagonist, (S)-UH301, are not mediated by the 5-HT 1A receptor

By Groenink L.   Van der Gugten J.   Mos J.   Maes R.A.A.   Oliver B.  

European Journal of Pharmacology, Vol. 272, Iss. 2, 1995-01 ,pp. : 177-183

Elsevier

Access to resources Recommend Favorite

Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht₆ receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task

By King M.   Spicer C.   Sleight A.   Marsden C.   Fone K.  

Psychopharmacology, Vol. 202, Iss. 1-3, 2009-01 ,pp. : 111-123

Springer Publishing Company

Access to resources Recommend Favorite

Effects of corticosterone on 5-HT 1A and 5-HT 2 receptor binding and on the receptor-mediated behavioral responses of rats

By Takao K.   Nagatani T.   Kitamura Y.   Yamawaki S.  

European Journal of Pharmacology, Vol. 333, Iss. 2, 1997-08 ,pp. : 123-128

Elsevier

Access to resources Recommend Favorite

Antiemetic effects of N-3389, a newly synthesized 5-HT 3 and 5-HT 4 receptor antagonist, in ferrets

By Minami M.   Endo T.   Tamakai H.   Ogawa T.   Hamaue N.   Hirafuji M.   Monma Y.   Yoshioka M.   Hagihara K.  

European Journal of Pharmacology, Vol. 321, Iss. 3, 1997-03 ,pp. : 333-342

Elsevier

Access to resources Recommend Favorite